findmyKOL

Lauren Krupp, MD

Enriched profile

Director, Multiple Sclerosis Comprehensive Care Center; Nancy Glickenhaus Pier Professor of Pediatric Neuropsychiatry, Department of Neurology, NYU Grossman School of Medicine · NYU Langone Health

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyNeurologyFocusMultiple Sclerosis Research Studies+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1997–2026

Lauren Krupp is Director, Multiple Sclerosis Comprehensive Care Center; Nancy Glickenhaus Pier Professor of Pediatric Neuropsychiatry, Department of Neurology, NYU Grossman School of Medicine at NYU Langone Health. OpenAlex indexes 445 publications with 32,655 citations (h-index 88); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.

Data verified 16 Oct 2026

Overview

Updated 16 Oct 2026

Lauren Krupp, M.D., is Director, Multiple Sclerosis Comprehensive Care Center at NYU Langone Health. The public record shows 445 publications with 32,655 citations (h-index 88), centered on Multiple Sclerosis Research Studies, Polyomavirus and related diseases, Peripheral Neuropathies and Disorders. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 11 companies, 5 NIH-funded awards (1997–2026).

  • Most recent indexed publication: 2026 · Neurology
  • Top research focus: Multiple Sclerosis Research Studies
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 11 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Multiple Sclerosis4 trialsAlzheimer's / DementiaPsoriasis / Psoriatic ArthritisPsoriasis (Derm)

Research focus

OpenAlex concept fingerprint
Multiple Sclerosis Research StudiesPolyomavirus and related diseasesPeripheral Neuropathies and DisordersPsoriasis: Treatment and PathogenesisDementia and Cognitive Impairment Research

Drugs & molecules

across trials, industry payments and publications
Solirisgeneric · EculizumabClinical trials—Industry payments1Publications1Kesimptageneric · OfatumumabClinical trials—Industry payments8Publications—Upliznageneric · InebilizumabClinical trials—Industry payments6Publications—Ocrevusgeneric · OcrelizumabClinical trials—Industry payments4Publications—Zeposiageneric · OzanimodClinical trials—Industry payments4Publications—Mavencladgeneric · CladribineClinical trials—Industry payments3Publications—Dayvigogeneric · LemborexantClinical trials—Industry payments1Publications—Ocrevus Zunovogeneric · Hyaluronidase / ocrelizumabClinical trials—Industry payments1Publications—Ultomirisgeneric · RavulizumabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Novartis Pharmaceuticals CorporationClinical trials—Industry payments8Amgen Inc.Clinical trials—Industry payments6EMD Serono, Inc.Clinical trials—Industry payments5Celgene CorporationClinical trials—Industry payments4F. Hoffmann-La Roche AGClinical trials—Industry payments3Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments2E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments2Stony Brook UniversityClinical trials2Industry payments—AstraZeneca Pharmaceuticals LPClinical trials—Industry payments1Eisai Inc.Clinical trials—Industry payments1Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Clinical trials1Industry payments—Genentech USA, Inc.Clinical trials—Industry payments1NYU Langone HealthClinical trials1Industry payments—Roche Products LimitedClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
445publications

Distinct works indexed by OpenAlex, matched via ORCID; 34 in PubMed.

32,655citations

Total citations across indexed works.

88h-index

Hirsch index (OpenAlex). i10-index 226.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
11companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 1997–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    45.5%
    Gabapentinoids17.7%
    Gabapentin100%
    Part D≥11 patients
    Potassium Channel Blocker15.5%
    Dalfampridine Er100%
    Part D<11 patients

    + 1 more class in this area

  • Musculoskeletal

    37.3%
    Central alpha-2 Adrenergic Agonist20%
    Tizanidine Hcl100%
    Part D≥11 patients
    gamma-Aminobutyric Acid-ergic Agonist17.3%
    Baclofen100%
    Part D≥11 patients
  • Cancer & immunology

    17.3%
    Sphingosine 1-phosphate Receptor Modulator10.5%
    Tascenso Odt52%Zeposia48%
    Part D<11 patients
    Pyrimidine Synthesis Inhibitor6.8%
    Teriflunomide100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

5 NIH research awards on record, funded 1997–2026 per NIH RePORTER. The latest:

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Emmanuelle L. Waubant126Leigh Elkins Charvet116Tanuja Chitnis112Bianca Weinstock‐Guttman90Mark Gorman88Moses Rodriguez86Anita Lesgold Belman85Jayne Ness81Jennifer S. Graves76JOHN W. ROSE76Soe Mar74Teri Schreiner72Gregory Scott Aaen72Theron Charles Casper67Jan‐Mendelt Tillema63Timothy Edward Lotze61Mary R. Rensel55Leslie A. Benson51Amy Tara Waldman49Michael Waltz44Michael Shaw40Benjamin M. Greenberg38Lisa F. Barcellos34Yolanda Wheeler33Janace Hart30Yolanda Harris30Patricia Katherine Coyle28Jennifer P. Rubin28Manu S. Goyal26Shelly Roalstad25Christopher Christodoulou25Giuseppina Pilloni24Kimberly A. O’Neill24Meghan S. Candee23Brenda Banwell23Ellen M. Mowry20Aaron W. Abrams19Lana Zhovtis Ryerson19E. Ann Yeh19Kathleen Sherman19

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/lauren-krupp-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    globalneurologyacademy.org/profiles/lauren-krupp-md/OwkdYG/biography

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globalneurologyacademy.org ↗
  • Other

    nyulangone.org/doctors/1447207154/lauren-b-krupp

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Founding Chair

    International Pediatric Multiple Sclerosis Study Group

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
  • Director

    Division of Multiple Sclerosis, NYU Langone Health

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.